Deborah H Telman Atri Cure, Inc. (ATRC) insider trading activity

ATRC Quotes by TradingView

Deborah H Telman is Director of AtriCure, Inc.. Currently has a direct ownership of 22,184 shares of ATRC, which is worth approximately $659,974. The most recent transaction as insider was on May 19, 2025, when has been sold 5,401 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 22.2K
32.18% 3M change
32.18% 12M change
Total Value Held $659,974

Deborah H Telman Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 19 2025
BUY
Grant, award, or other acquisition
-
5,401 Added 19.58%
22,184 Common Stock
May 13 2024
BUY
Grant, award, or other acquisition
-
7,788 Added 31.7%
16,783 Common Stock
May 25 2023
BUY
Grant, award, or other acquisition
-
3,186 Added 26.16%
8,995 Common Stock
May 25 2022
BUY
Grant, award, or other acquisition
-
3,564 Added 38.02%
5,809 Common Stock
Jun 15 2021
BUY
Grant, award, or other acquisition
-
2,245 Added 50.0%
2,245 Common Stock

Also insider at

OGN
Organon & Co. Healthcare
EVP GC & Corporate Secretary
GILD
GILEAD SCIENCES, INC. Healthcare
EVP, Corporate Affairs & GC
DHT

Deborah H Telman

Director
Jersey City, NJ

Track Institutional and Insider Activities on ATRC

Follow AtriCure, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ATRC shares.

Notify only if

Insider Trading

Get notified when an Atri Cure, Inc. insider buys or sells ATRC shares.

Notify only if

News

Receive news related to AtriCure, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ATRC